Home > Offer to Sell > Intermediates > Pharmaceutical intermediates > Canertinib dihydrochloride

Canertinib dihydrochloride

Inquiry
  Post Date: Apr 22,2024
  Expiry Date: Oct 19,2024
  Detailed Description: Cas No. :289499-45-2 CANERTINIB DIHYDROCHLORIDE;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride;Canertinib.2HCL;CI-1033;N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride;Canertinib HCl;CI 103

  CAS Registry Number:

289499-45-2
  Synonyms: ;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride;N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride;N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[2-(morpholin-4-yl)ethoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride;Canertinib 2HCl;
  Molecular Formula: C24H25ClFN5O3
  Molecular Weight: 485.9384
  Molecular Structure: 289499-45-2 Canertinib dihydrochloride

  Company: Nanjing CHICO pharmaceutical Co.,Ltd     [ China ]          
  Contact: Mr WU
  Tel: +86-25-84351604
  Fax: +86-25-52261140
  Email: sales@chicopharm.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.